Analysis of treatment outcomes in patients with progressive locally advanced non-resectable and disseminated medullary thyroid cancer receiving vandetanib outside of clinical trials (Russian experience)

Analysis of treatment outcomes in patients with progressive locally advanced non-resectable and disseminated medullary thyroid cancer receiving vandetanib outside of clinical trials (Russian experience)

The study objective is to perform retrospective analysis of the efficacy and safety of vandetanib for metastatic and non-resectable medullary thyroid cancer in routine clinical practice. Materials and methods. We analyzed treatment outcomes in 46 patients treated with vandetanib. We also evaluated p...

Full description

Bibliographic Details
Main Authors: I. S. Romanov, А. М. Mudunov, S. О. Podvyaznikov, А. V. Ignatova, Yu. V. Alymov
Format: Article
Language:Russian
Published: ABV-press 2020-07-01
Series:Opuholi Golovy i Šei
Subjects:
medullary thyroid cancer
vandetanib
tyrosine kinase inhibitors
survival
adverse events
Online Access:https://ogsh.abvpress.ru/jour/article/view/526

Similar Items

Similar Items